Cellino’s Post

🔬𝐓𝐡𝐞 𝐈𝐫𝐨𝐧𝐲 𝐨𝐟 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 You’d think with all our fancy tech and decades of scientific breakthroughs, drug discovery would be faster and cheaper than ever before, right? Well, think again. The cost to launch a new drug has actually doubled every nine years since the '90s, inflation-adjusted. Instead of ditching old methods for new ones, we've just piled them on top of each other. The result? A bloated, overly complex process that feels more like navigating a maze than pioneering medicine. And then there's AI and big data. Promised as the great simplifiers, they often just add another layer of complexity. So much for cutting through the noise. What we really need isn't to do more—it's to do less, but smarter. We need clarity, not clutter. We need to sharpen our focus, not broaden it. Can we shift from adding more experiments to honing in on the ones that truly matter? Can we simplify the path to innovation instead of complicating it? Let’s chat about how we can truly streamline drug discovery. What’s your take? #DrugDiscovery #DrugDevelopment #Pharma

AI transforming drug discovery. Personalised medicine revolutionising patient care. Sustainability reshaping industry priorities. These aren’t just trends—they’re the forces driving change in the life sciences sector. As we look to 2025, one thing is clear: staying competitive requires more than innovation. It demands understanding the challenges posed by changing regulations, global equity gaps, and the need for sustainable practices. In our latest blog, we delve into the key developments shaping life sciences and provide actionable insights for industry professionals. Whether you're in biotech, pharma, or healthcare, these trends will define the future of your work. 🌐 Read the blog here: https://bit.ly/4ffendu #LifeSciences2025 #AIinBiotech #PersonalisedMedicine #Sustainability #HealthcareInnovation #BiotechLeaders

Cutting-edge AI-driven software is revolutionizing #biomarker research. The recent webinar hosted by Danaher Corporation, in collaboration with Leica Microsystems and Genedata, showcased how AI enables faster discoveries in biopharma – making drug development smarter, quicker, and more precise.       You missed it?  Rewatch it here: https://lnkd.in/dNm_YgQ5 #GenedataProfiler #DigitalizingBiopharma  

Book your seat for a great session on AI in #biotech #medtech. Come and listen to my expert colleagues Dr. Andrea Schmoll and Vladimir Murovec.

⚡ Next week in New York, Endpoints News + the Financial Times are teaming up for the first time as we co-present the US #Pharma and #Biotech Summit on May 16. We'll be talking antitrust + competition, AI, the market macro environment, America's life expectancy crisis, the evolving questions of who "owns" the patient relationship and MUCH more. Some speaker highlights: * FDA's Tala Fakhouri, Associate Director for Policy Analysis * Federal Trade Commission 's Rahul Rao, Deputy Director, Bureau of Competition * Biogen CEO Christopher Viehbacher * Ro CEO/Co-founder Zachariah Reitano * Eikon Therapeutics CEO Roger M. Perlmutter And a ton more. It's stacked, it's gonna be great, and I can't wait to see you there. https://lnkd.in/exXQF5uH

"🌐💊 Big Tech Meets Biopharma! Get ready for a groundbreaking transformation at #JPM2024, where AI is set to redefine drug discovery! From advanced algorithms to personalized medicine, the future of healthcare is here. #AIinHealthcare #DrugDiscovery 🚀💡"

🧠💉 6 Ways AI is Revolutionising Healthcare: Drug Discovery, Diagnostics, and Personalised Medicine 💉🧠 Following our post about new digital innovations in the healthcare & life science industry, we delve deeper into how AI is reshaping the future of healthcare... How do you think AI will continue to shape the future of our healthcare industry? 🤔 #AIinHealthcare #DrugDiscovery #PrecisionMedicine #MedicalImaging #Bioinformatics #HealthcareInnovation #DigitalHealth #LifeSciences #FutureOfHealthcare #MentalHealthTech

How is AI transforming drug discovery? 🚀 Ben Gmeiner from Novartis shares how AI is driving faster, more efficient breakthroughs in healthcare. #AIInnovation #HealthcareTech #DrugDiscovery #MedTech

Is your drug development strategy ready for 2025? Beyond traditional challenges like regulatory hurdles and market access, pharma and biotech developers now need to leverage real-world data, patient-reported outcomes, epidemiological data and advanced AI/ML to demonstrate value. Drug developers will need to introduce new practices such as ensuring representative populations in clinical trials, using synthetic twin comparator arms, exploring alternative study designs and/or collecting data from digital devices. Watch Mike Ward, Head of Thought Leadership, LS&H, Clarivate talk about the evolving trends in 2025 as he sheds light on the upcoming Drugs to Watch report. #DrugDevelopment #AI #RealWorldEvidence #RegulatoryAffairs #PatientOutcomes #GeneEditing #DrugsToWatch

How is AI transforming drug discovery? 🚀 Ben Gmeiner from Novartis shares how AI is driving faster, more efficient breakthroughs in healthcare. #AIInnovation #HealthcareTech #DrugDiscovery #MedTech